Overview

TRACE: Tirapazamine-Radiation And Cisplatin Evaluation

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Collaborator:
Groupe Oncologie Radiotherapie Tete et Cou
Treatments:
Cisplatin
Tirapazamine